Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study
Journal of Geriatric Oncology(2021)
Abstract
Advanced age is not associated with immune-related adverse drug reactions of PD-1 and PD-L1 inhibitors.
MoreTranslated text
Key words
Adverse drug reactions,Elderly,Immune checkpoint inhibitors,PD-1 inhibitors,PD-L1 inhibitors,Real-world data,Safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined